Our experienced regulatory affairs professionals understand how to navigate the complex and ever-changing regulatory landscape so you can seamlessly move your product through development.
Your needs are variable—sometimes you need a full-time resource, while other times you need flexible support. Whether you’re looking for on-demand short- or long-term support with individuals or teams, we can help.
We have depth of experience supporting clients to clarify goals, capabilities, timing, and gaps to present you with custom-crafted solutions. We leverage your internal team or outsourced providers and fill any gaps you may have.
Whether developing broad regulatory development plans or fit-for-purpose regulatory strategies, we help you navigate regulatory complexities with strategic pathways to navigate the regulatory landscape.
Our regulatory leads, regulatory project managers, and Reg Ops professionals can help you meet your current objectives, from performing day-to-day tasks and developing Briefing Books to leading major submission teams.
Grow, streamline, or improve operations by a review of current processes and ensure fit-for-purpose SOPs and work instructions, systems, and controls are in place.
Meet with a member of our team to find the right solutions for your life sciences company.
Talk to UsIndustry Insights
By Dr. Julie Rosenberg Bringing a new drug to market is a long, complex, and costly journey and regulatory approval is not guaranteed. For Biotech and pharmaceutical, companies, the New Drug Application (NDA) submission is a pivotal moment—a culmination of years of research, development, and clinical testing. Many applications stumble at the finish line. Understanding […]
Industry Insights
By Julie Rosenberg, MD Biopharma startups often need senior-level expertise as they navigate the drug development process. However, hiring a full-time executive can be financially out of reach. These companies must be strategic about when and where they should bring in external drug development advisory. Whether a biopharma startup is looking for interim leadership, regulatory […]
Industry Insights
By Jenny Thayer, BioBridges’ Medical, Regulatory, and Scientific Communications SME While an open-minded approach to onboarding new technology is essential to advancing drug and device development, a thoughtless approach can cause additional stress, challenges, and ultimately resistance to technologies over time. Following, I explore how thoughtlessly incorporating technology can cause additional headaches, and ways […]
Industry Insights
The life sciences job market is experiencing significant shifts, and we anticipate this will continue throughout 2025 with a greater focus on roles that support product innovation, regulatory compliance, emerging technologies, and real-world evidence to demonstrate a product’s potential, clinical impact, and economic value. According to Deloitte’s 2025 Life Sciences Outlook, “The life sciences industry […]
Industry Insights
MedTech companies have had challenges obtaining investor funding and have been operating with lean teams this past year. Will this continue into 2025, or will there be a resurgence of capital? We talked to leading industry experts to get their take on what’s next for MedTech. Listen to the full webinar Here are some highlights […]
Industry Insights
Working in life sciences is exciting because of the ever-changing landscape. In a constantly evolving industry, new regulations and legislation continuously emerge. As a life sciences professional, staying current is imperative for your career. Here are five critical regulatory changes that you need to understand: #1) Concurrent Submission and Review of Oncology Products As you […]
Industry Insights
The client was preparing to start a major submission for a marketing authorization in a rare disease and was faced with critical timelines and a complex development program. They needed their Clinical Submission Team Lead to be decisive yet adaptive during what was expected to be a challenging submission process.
Industry Insights
As an established pharmaceutical company focused on neurological diseases was preparing for a submission and realized that they had not fully completed the necessary quality GMP and GCP activities during the course of the program.
Industry Insights
An emerging cellular therapeutics company was entering phase 1 clinical testing for their lead hematology candidate based on their antibody-coupled T-cell receptor (ACTR) technology. In order to move their vision for a singular therapeutic platform approach to treat many different cancers through the development process, they needed a plan, processes and hands-on support.
Industry Insights
A premier academic institution and research center with critical partnerships with large pharma, biotech, and device organizations recognized a gap: they required industry experience to effectively collaborate with their sponsor partners. Additionally, our client faced the emerging challenges of managing the ever-changing considerations resulting from COVID-19, which were amplified due to their lack of experience with a remote work force.
